| Literature DB >> 36199606 |
Huihua Zhang1,2, Hui Qu1,2, Jingbo Cui1,2, Linxia Duan1,2.
Abstract
The sensitive and specific detection of tumor biomarkers is crucial for early diagnosis and treatment of malignant melanoma. Immunoassay with a simple sensing interface and high sensitivity is highly desirable. In this work, a simple electrochemical immunosensor based on a chitosan/reduced graphene oxide (CS-rGO) nanocomposite was developed for sensitive determination of an S-100B protein, a tumor marker of malignant melanoma. CS-rGO nanocomposite were prepared by chemical reduction of graphene oxide in the presence of chitosan and modified on glassy carbon electrode (GCE) to provide a biofriendly, conductive, and easily chemically modified matrix for further immobilization of antibodies. Anti-S-100B antibodies were grafted onto the chitosan molecules to fabricate the immunorecognition interface by a simple glutaraldehyde cross-linking method. Electrochemical determination of S-100B was achieved by measuring the decreased current signal of solution phase electrochemical probes, which originated from the increased steric hindrance and insulation caused by the formation of antigen-antibody complexes at the electrode interface. Due to the good conductivity, high surface area, excellent biocompatibility, and good film-forming ability of CS-rGO, the constructed immunosensor exhibited good stability, high selectivity and sensitivity, a wide dynamic range from 10 fg mL-1 to 1 ng mL-1 and a low limit of detection of 1.9 pg mL-1 (S/N = 3). Moreover, the sensor was also applicable for the sensitive detection of S-100B protein in real human serum samples. This journal is © The Royal Society of Chemistry.Entities:
Year: 2022 PMID: 36199606 PMCID: PMC9465697 DOI: 10.1039/d2ra04208h
Source DB: PubMed Journal: RSC Adv ISSN: 2046-2069 Impact factor: 4.036
Fig. 1Schematic illustration for the fabrication of immunosensor based on CS–rGO and the electrochemical determination of S-100B.
Fig. 2(A) SEM image of CS–rGO film modified on GCE. (B) UV-vis spectra of GO and CS–rGO.
Fig. 3(A) FR-IR spectra of CS, CS–rGO, and rGO synthesized without CS. (B) Relationship between I vs. v1/2 derived from the CVs of bare GCE and CS–rGO/GCE obtained in 0.5 mM K3[Fe(CN)6] containing 0.1 M KCl.
Fig. 4CV (A) and DPV (B) curves obtained on different electrodes obtained in the fabrication of the immunosensor or after incubated with S-100B in Fe(CN)63−/4− solution.
Fig. 5(A) DPV curves of the immunosensor in the presence of different concentration (10 fg mL−1 to 1 ng mL−1) of S-100B. (B) Calibration curve for the determination of S-100B.
Fig. 6The currents obtained on the developed immunosensor in absence (control) or presence of the indicated tumor biomarker.
Determination of S-100B in human serum samples
| Sample | Added (pg mL−1) | Found (pg mL−1) | RSD (%, | Recovery (%) |
|---|---|---|---|---|
| Human serum | 5.00 | 4.87 | 3.4 | 97.4 |
| 50.0 | 52.6 | 1.4 | 105 | |
| 500 | 488 | 3.5 | 97.6 |